Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Bohai Pharma Announces New Products

publication date: Sep 16, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Bohai Pharmaceuticals Group, a TCM pharmaceutical company, said it has added five marketed products to its portfolio so far this year, bringing its total to fifteen. Bohai holds the rights to produce another 14 TCM formulations in China. Bohai completed its reverse merger earlier this year and reported $45 million in revenue for the first nine months of fiscal 2010. More details....

Stock Symbol: (OTCBB: BOPH)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



ChinaBio® Events
Suzhou, China
May 18 - 19, 2016
Record attendance of 1008!
See us next year in Shunde!

>> More events...

Other Events
Hong Kong, China
June 15–17, 2016
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors